(EMAILWIRE.COM, January 30, 2020 ) Metabolomics is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples. This metabolomics technology market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography. These techniques are used in metabolome studies, primarily in toxicology testing and developing personalized medicine.

The metabolomics has witnessed significant growth primarily due to the increasing need for accurate diagnosis of diseases, rising demand for personalized medicine, and emergence of advanced technologies. However, need for well-qualified researchers, issues related to data examination and processing, and the high cost of tools and instruments are restraining the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=900

Industry Growth Drivers:

• Availability of government and private funding
• Increasing pharmaceutical and biotech R&D expenditure
• Technological advancements
• Growing demand for personalized medicine
• Increasing use of metabolomics in toxicology testing

Market by Geography:

• North America
• Europe
• Asia Pacific (APAC)
• Latin America
• Middle East & Africa

Key Market Trend:

The growing use of hyphenated technologies is likely to provide the largest growth opportunity for metabolomics market players Over the past four years, a number of hyphenated systems have been launched by market players. Hyphenated technology is a combination of two or more analytical tools. Hyphenated technologies reduce costs by requiring the installation of a single instrument. They also provide ease of operation and require lesser space as compared to the installation of two or more standalone devices. In addition, these technologies have broadened the applications of analytical techniques in the analysis of biomaterials, especially natural products.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=900

Key Questions Addressed in Research Study:

• Most of the metabolomics market players have new product launch and product enhancements as the key growth strategies. Where will it take the industry in the mid to long term?

• How are the potential areas for investment using strategic evaluation in the metabolomics technology market?

Growing Demand for Personalized Medicine Drive the Metabolomics Market;

The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient’s symptoms. Recent developments in analytical technologies, such as the emergence of high-resolution mass spectrometry, have provided revolutionary analytical capabilities in metabolomics, offering the detection of more than 10,000 metabolites at a given point of time.

Leading Key Players in Overall Metabolomics Market:

Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.), Biocrates Life Sciences AG (Austria), Human Metabolome Technologies Inc. (Japan), LECO Corporation (U.S.), and Metabolon Inc. (U.S.). A majority of the leading players in this market are based in developed countries across North America and Europe.